Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02918851Phase 4Completed
Phase 4, randomised, single-blind trial of red blood cells in anemia (3 arms), sponsored by Stony Brook University. Primary endpoint: Percent Change From Baseline in Maximal Oxygen Uptake at Day 2. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02918851.